FDA.reportPublic FDA data

The Prestige

Manufacturer
Pharmicell Co., Ltd.
Effective date
2014-09-22
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:40:15

Label at a glance#

ProductThe Prestige
Active ingredientGLYCERIN
Label structure8 sections

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active ingredient : GLYCERIN 20%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive ingredients : WATER, HUMAN BONE MARROW STEM CELL CONDITIONED MEDIA, BUTYLENE GLYCOL, CETYL ETHYLHEXANOATE, HYDROGENATED POLYDECENE, CETEARYL ALCOHOL, NIACINAMIDE, HYDROGENATED VEGETABLE OIL, VEGETABLE OIL, BUTYROSPERMUM PARKII(SHEA BUTTER), DIPENTAERYTHRITYL HEXA C5-9 ACID ESTERS, POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE, CITRUS PARADISI (GRAPEFRUIT) FRUIT EXTRACT, STEARIC ACID, CETEARETH-20, DIMETHICONE, GLYCERYL STEARATE, MACADAMIA TERNIFOLIA SEED OIL, CETYL PEG/PPG-10/1 DIMETHICONE, 1,2-HEXANEDIOL, PHENOXYETHANOL, HYDROGENATED LECITHIN, XANTHAN GUM, SODIUM POLYACRYLATE, PANAX GINSENG ROOT EXTRACT, CLADOSIPHON OKAMURANUS EXTRACT, ALTHAEA ROSEA ROOT EXTRACT, ALOE BARBADENSIS LEAF EXTRACT, CERAMIDE 3, NEOFINETIA FALCATA CALLUS CULTURE EXTRACT, ZANTHOXYLUM PIPERITUM FRUIT EXTRACT, PULSATILLA KOREANA EXTRACT, USNEA BARBATA (LICHEN) EXTRACT, LECITHIN, DEXTRIN, POLYACRYLATE-13, POLYISOBUTENE, POLYSORBATE 20, ADENOSINE, CITRUS MEDICA LIMONUM (LEMON) FRUIT OIL, JASMINUM OFFICINALE (JASMINE) OIL, ROSA CENTIFOLIA FLOWER OIL, SODIUM HYALURONATE

PURPOSE

OTC - PURPOSE SECTION

Purpose : Skin Protectant

WARNINGS

WARNINGS SECTION

Warnings : Harmful if swallowed. Avoid contact with the eyes. Keep out of reach of children. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

Indication and usage : After pumping a proper amount of the essence, spread it evenly along the lines of the face for sufficient absorption.
- For effective use, this product is recommended to be used with the prestige essence.

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage and administration : Take a proper amount of the product and spread it evenly over the entire face.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GLYCERIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
60949-180-012019-11-27C16284748780-19855e2a2-4dfa-60a7-e053-dbdaa90a05bd839c1bd4-aae3-41cf-8cf1-5f5b3ce02d6a

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60949-180-01The Prestige50 g in 1 CARTONCREAM501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60949-180THE PRESTIGE (GLYCERIN) CREAM [PHARMICELL CO., LTD.]1Legacy NDC, 1 package rows20140922_839c1bd4-aae3-41cf-8cf1-5f5b3ce02d6a.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
GLYCERINACTIVE INGREDIENTPDC6A3C0OX1
GLYCERINACTIVE MOIETYPDC6A3C0OX1
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
60949-18060949-180-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
GLYCERINPDC6A3C0OXACTIB
WATER059QF0KO0RIACT
BUTYLENE GLYCOL3XUS85K0RAIACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 2 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii candidate
2 equally ranked IID candidates
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TRANSDERMAL8.12 mgExact identifier — unii candidate
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
7b1ea48d-d4f3-4116-95a3-8502305d8c85839c1bd4-aae3-41cf-8cf1-5f5b3ce02d6a2014-09-22WarningsExact identifier
spl id: 7b1ea48d-d4f3-4116-95a3-8502305d8c85
spl set id: 839c1bd4-aae3-41cf-8cf1-5f5b3ce02d6a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.